• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

SARS-CoV-2 variants of concern and variants under investigation in England

Mary Wilson

Well-known member
Public Health England
9 July 2021

Technical briefing 18
This briefing provides an update on previous briefings up to 25 June 2021

Summary

There are 4 current variants of concern and 9 variants under investigation (Table 1).

This report has been published to continue sharing detailed surveillance of Delta (VOC- 21APR-02, B.1.617.2). A separate report is published covering our routine data on all other variants of concern and variants under investigation. The specialist technical briefings contain early data and analysis on emerging variants and findings have a high level of uncertainty.

Principal changes and findings this week are:
  •  Delta variant accounted for approximately 99% of sequenced and 97% genotyped cases from 27 June to 3 July 2021
  •  the number of genome sequence results available is maintained but the coverage has fallen with the increasing case numbers
  •  secondary attack rates have fallen but remain higher for Delta than for Alpha. New data is included on the prevalence of mutations of predicted antigenic significance in the global dataset – there is an increase in mutations of predicted antigenic significance over time, even outside the designated variants of concern and variants under investigation
  •  additional spike mutations are occurring on Delta but are present at relatively low frequencies both in the UK and global datasets
  •  there is an increase in PCR positivity in the SIREN (national healthcare worker) cohort and a small but increasing number of possible reinfections
  •  two new variants in monitoring have been designated (B.1.619 and B.1.629, Table 1)
https://assets.publishing.service.g...ants_of_Concern_VOC_Technical_Briefing_18.pdf
 
Back
Top Bottom